GENE ONLINE|News &
Opinion
Blog

M&A
M&A NovartisRadiopharmaceuticals
Novartis Invests $745M to Compete with BMS and Lilly in the Radiopharma Race
2024-11-19
M&A patent expirations
Big Pharma’s Next Move: BMS, Merck, Amgen Eye M&A to Tackle Patent Expirations
2024-11-14
Trending PartnershipsAI
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Deals AcquisitionsVertex Pharmaceuticals
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
M&A Market Growth
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
M&A AstraZenecaAcquisitions
AstraZeneca’s Latest Moves in Pharmaceuticals in Q1 2024
2024-03-21
M&A GSKGlaxoSmithKlineAsthmam&a
GSK Completed the Acquisition of Aiolos Bio, Enhancing the Respiratory Portfolio of Asthma
2024-02-16
M&A Gilead Sciences
Gilead Sciences Acquires CymaBay for $4.3 billion, Heralding a New Era in PBC Treatment
2024-02-15
M&A ObesityNovo NordiskCatalent
Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity
2024-02-07
M&A acquisition
Olympus Completes Acquisition of Taewoong Medical, Expanding GI EndoTherapy Portfolio
2024-01-29
M&A SanofiRare Disease
Sanofi Announces First Acquisition Deal of 2024 to Strengthen Rare Disease Portfolio at $2.2 Billion
2024-01-24
M&A TaiwanBora Pharmaceuticals
Bora Pharmaceuticals Makes First U.S. Acquisition to Buy Upsher-Smith for $210 Million
2024-01-17
JPM 2024 JPMJP Morgan 2024
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest
2024-01-10
M&A m&aBristol Myers SquibbKaruna TherapeuticsNeuroscience
Bristol Myers Squibb Acquires Karuna Therapeutics to Enhance Neuroscience Portfolio
2023-12-25
M&A Ovarian Cancer
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
1 2 3 … 14
LATEST
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top